3-Fluoro-5-(trifluoromethyl)picolinaldehyde, 95.0%, 5g

Potassium trifluoro(4-fluoro-2-methylbenzyl)borate, 98%, 250mg

(5-Methoxypyridine-2-yl)methanol, 95.0%, 25g

ethyl 5-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-4-carboxylate, 95+%, 250mg

Ethyl 4-nitro-1H-pyrrole-2-carboxylate, 95.0%, 1g

2-Chloro-4-hydrazinylbenzonitrile, 95%, 250mg

N-(2-(3,4-Dimethoxyphenyl)ethyl)-2-nitriloethanamide, 98%, 98.0%, 1g

L-4-FLUOROTRYPTOPHAN, 95.0%, 100mg

2-Amino-1-isopropylbenzimidazole, 95.0%, 250mg

Methyl 5-methoxy-2-nitrobenzoate, 95.0%, 10g

Plan phase PLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

2-Chloro-6-fluoro-3-(methoxymethoxy)benzoic acid, 98%, 1g

(6-Chloro-2-methylsulfanyl-pyrimidin-4-yl)-methyl-amine, 100mg